The HBx protein of hepatitis B virus confers resistance against nucleolar stress and anti-cancer drug-induced p53 expression

FEBS Letters

Volumn 587, Issue 9, 2013, Pages 1287-1292

  Kapoor, Neetu Rohit ^a   Ahuja, Richa ^a   Shukla, Surendra K ^a   Kumar, Vijay ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Drug resistance; HBx; MDM2; Nucleolar stress; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; DACTINOMYCIN; DNA DIRECTED RNA POLYMERASE; DOXORUBICIN; HEPATITIS B VIRUS X PROTEIN; MYC PROTEIN; PACLITAXEL; PROTEIN L 11; PROTEIN MDM2; PROTEIN P53; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA TRANSCRIPTION;

ANTINEOPLASTIC AGENTS; CELL NUCLEOLUS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; PACLITAXEL; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS C-MYC; RIBOSOMAL PROTEINS; RNA POLYMERASE I; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

HEPATITIS B VIRUS;

EID: 84876472441     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.03.004     Document Type: Article

References (32)

1. C. Deisenroth, and Y. Zhang Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway Oncogene 29 2010 4253 4260
2. N. Nalabothula, F.E. Indig, and F. Carrier The nucleolus takes control of protein trafficking under cellular stress Mol. Cell. Pharmacol. 2 2010 203 212
3. S. Boulon, B.J. Westman, S. Hutten, F.M. Boisvert, and A.I. Lamond The nucleolus under stress Mol. Cell 40 2010 216 227
4. J.A. Hiscox The nucleolus-a gateway to viral infection? Arch. Virol. 147 2002 1077 1089
5. F.M. Boisvert, S. van Koningsbruggen, J. Navascues, and A.I. Lamond The multifunctional nucleolus Nat. Rev. Mol. Cell Biol. 8 2007 574 585
6. J.A. Hiscox RNA viruses: hijacking the dynamic nucleolus Nat. Rev. Microbiol. 5 2007 119 127
7. A. Greco Involvement of the nucleolus in replication of human viruses Rev. Med. Virol. 19 2009 201 214
8. S. Martin-Vilchez, E. Lara-Pezzi, M. Trapero-Marugan, R. Moreno-Otero, and P. Sanz-Cameno The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection Rev. Med. Virol. 21 2011 315 329
9. R. Perez-Tomas Multidrug resistance: retrospect and prospects in anti-cancer drug treatment Curr. Med. Chem. 13 2006 1859 1876
10. J.H. Kim, W.S. Kim, Y. Yun, and C. Park Epstein-Barr virus latent membrane protein 1 increases chemo-resistance of cancer cells via cytoplasmic sequestration of Pim-1 Cell Signal. 22 2010 1858 1863
11. A. Fun, A.M. Wensing, J. Verheyen, and M. Nijhuis Human immunodeficiency virus Gag and protease: partners in resistance Retrovirology 9 63 2012
12. H. Thai, D.S. Campo, J. Lara, Z. Dimitrova, S. Ramachandran, G. Xia, L. Ganova-Raeva, C.G. Teo, A. Lok, and Y. Khudyakov Convergence and coevolution of hepatitis B virus drug resistance Nat. Commun. 3 2012 789
13. N. Kalra, and V. Kumar The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc FEBS Lett. 580 2006 431 436
14. H.F. Horn, and K.H. Vousden Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway Oncogene 27 2008 5774 5784
15. S.K. Shukla, and V. Kumar Hepatitis B virus X protein and c-Myc cooperate in the upregulation of ribosome biogenesis and in cellular transformation FEBS J. 279 2012 3859 3871
16. M.S. Dai, H. Arnold, X.X. Sun, R. Sears, and H. Lu Inhibition of c-Myc activity by ribosomal protein L11 EMBO J. 26 2007 3332 3345
17. K.B. Challagundla, X.X. Sun, X. Zhang, T. DeVine, Q. Zhang, R.C. Sears, and M.S. Dai Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress Mol. Cell. Biol. 31 2011 4007 4021
18. C. Blattner, T. Hay, D.W. Meek, and D.P. Lane Hypophosphorylation of Mdm2 augments p53 stability Mol. Cell. Biol. 22 2002 6170 6182
19. L. Xian, J. Zhao, J. Wang, Z. Fang, B. Peng, W. Wang, X. Ji, and L. Yu P53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2 Mol. Biol. Rep. 37 2010 2935 2940
20. R. Truant, J. Antunovic, J. Greenblatt, C. Prives, and J.A. Cromlish Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation J. Virol. 69 1995 1851 1859
21. C.V. Rao, C.D. Kurkjian, and H.Y. Yamada Mitosis-targeting Natural Products for Cancer Prevention and Therapy Curr. Drug Targets 13 2012 1820 1830
22. F.A. Fornari, J.K. Randolph, J.C. Yalowich, M.K. Ritke, and D.A. Gewirtz Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol. Pharmacol. 45 1994 649 656
23. S. Adhikary, and M. Eilers Transcriptional regulation and transformation by Myc proteins Nat. Rev. Mol. Cell Biol. 6 2005 635 645
24. Bursac, S., Brdovcak, M.C., Pfannkuchen, M., Orsolic, I., Golomb, L., Zhu, Y., Katz, C., Daftuar, L., Grabusic, K., Vukelic, I., Filic, V., Oren, M., Prives, C. and Volarevic, S. (2012) Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc. Natl. Acad. Sci. USA. 109, 20467-20467.
25. S. Araki, J.A. Eitel, C.N. Batuello, K. Bijangi-Vishehsaraei, X.J. Xie, D. Danielpour, K.E. Pollok, D.A. Boothman, and L.D. Mayo TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer J. Clin. Invest. 120 2010 290 302
26. C. Cordon-Cardo, E. Latres, M. Drobnjak, M.R. Oliva, D. Pollack, J.M. Woodruff, V. Marechal, J. Chen, M.F. Brennan, and A.J. Levine Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas Cancer Res. 54 1994 794 799
27. S. Knoll, K. Furst, S. Thomas, S. Villanueva Baselga, A. Stoll, S. Schaefer, and B.M. Putzer Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC Cell Cycle 10 2011 3554 3565
28. D. Drygin, W.G. Rice, and I. Grummt The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer Annu. Rev. Pharmacol. Toxicol. 50 2010 131 156
29. A. Kanakkanthara, and J.H. Miller MicroRNAs: novel mediators of resistance to microtubule-targeting agents Cancer Treat. Rev. 39 2013 161 170
30. H.H. Thein, S.R. Walter, H.F. Gidding, J. Amin, M.G. Law, J. George, and G.J. Dore Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort Hepatol. Res. 42 2012 1175 1186
31. X. Yue, H. Wang, F. Zhao, S. Liu, J. Wu, W. Ren, and Y. Zhu Hepatitis B virus-induced calreticulin protein is involved in IFN resistance J. Immunol. 189 2012 279 286
32. Y. Liu, G. Lou, W. Wu, M. Zheng, Y. Shi, D. Zhao, and Z. Chen Involvement of the NF-kappaB pathway in multidrug resistance induced by HBx in a hepatoma cell line J. Viral Hepat. 18 2011 e439 446